Commercialisation

SARTATE trial results to be presented at the upcoming 2016 SNMMI Meeting

Clarity’s strong collaboration with Associate Professor Paul Donnelly at the School of Chemistry and Bio21 Institute, University of Melbourne enabled the initial manufacture and development of the product that was then translated into the clinic in the recently completed SARTATE™ proof-of-concept clinical trial for neuroendocrine tumours (NETs).

Bio21 Researchers' ARC Linkage Success

ARC Linkage

The ARC Linkage Project funding outcomes were announced 7 July 2015.

Lithuanian Delegation visits Bio21 Institute

Lithuanian Delegation

The Lithuanian Minister for Foreign Affairs Linas Antanas Linkevičius and his delegation toured Bio21 Institute, 24th March 2015.

Subscribe to RSS - Commercialisation